Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 19 de 19
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Infect Immun ; 91(4): e0049622, 2023 04 18.
Artículo en Inglés | MEDLINE | ID: mdl-36912636

RESUMEN

Among the unfavorable conditions bacteria encounter within the host is restricted access to essential trace metals such as iron. To overcome iron deficiency, bacteria deploy multiple strategies to scavenge iron from host tissues, with abundant examples of iron acquisition systems being implicated in bacterial pathogenesis. Yet the mechanisms utilized by the major nosocomial pathogen Enterococcus faecalis to maintain intracellular iron balance are poorly understood. In this study, we conducted a systematic investigation to identify and characterize the iron acquisition mechanisms of E. faecalis and to determine their contribution to virulence. Bioinformatic analysis and literature surveys revealed that E. faecalis possesses three conserved iron uptake systems. Through transcriptomics, we discovered two novel ABC-type transporters that mediate iron uptake. While inactivation of a single transporter had minimal impact on the ability of E. faecalis to maintain iron homeostasis, inactivation of all five systems (Δ5Fe strain) disrupted intracellular iron homeostasis and considerably impaired cell growth under iron deficiency. Virulence of the Δ5Fe strain was generally impaired in different animal models but showed niche-specific variations in mouse models, leading us to suspect that heme can serve as an iron source to E. faecalis during mammalian infections. Indeed, heme supplementation restored growth of Δ5Fe under iron depletion and virulence in an invertebrate infection model. This study revealed that the collective contribution of five iron transporters promotes E. faecalis virulence and that the ability to acquire and utilize heme as an iron source is critical to the systemic dissemination of E. faecalis.


Asunto(s)
Transportadoras de Casetes de Unión a ATP , Proteínas Bacterianas , Transporte Biológico , Enterococcus faecalis , Hierro , Enterococcus faecalis/metabolismo , Enterococcus faecalis/patogenicidad , Virulencia , Transportadoras de Casetes de Unión a ATP/genética , Transportadoras de Casetes de Unión a ATP/metabolismo , Hierro/metabolismo , Regulación Bacteriana de la Expresión Génica , Proteínas Bacterianas/metabolismo , Hemo/metabolismo , Infecciones por Bacterias Grampositivas/metabolismo , Infecciones por Bacterias Grampositivas/microbiología , Humanos
2.
J Photochem Photobiol B ; 234: 112547, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-36030693

RESUMEN

Knowledge of photo-oxidative stress responses in bacteria that survive antimicrobial photodynamic therapy (aPDT) is scarce. Whereas aPDT is attracting growing clinical interest, subsequent stress responses are crucial to evaluate as they may lead to the up-regulation of pathogenic traits. Here, we aimed to assess transcriptional responses to sublethal aPDT-stress and identify potential connections with virulence-related genes. Six Enterococcus faecalis strains were investigated; ATCC 29212, three dental root-canal isolates labelled UmID1, UmID2 and UmID3 and two vancomycin-resistant isolates labelled A1 and A2. TMPyP was employed as a photosensitiser. A viability dose-response curve to increasing concentrations of TMPyP was determined by culture plating. Differential expression of genes involved in oxidative stress responses (dps and hypR), general stress responses (dnaK, sigma-factorV and relA), virulence-related genes (ace, fsrC and gelE) and vancomycin-resistance (vanA) was assessed by reverse-transcription qPCR. TMPyP-mediated aPDT inactivated all strains with comparable efficiencies. TMPyP at 0.015 µM was selected to induce sublethal photo-oxidative stress. Despite heterogeneities in gene expression between strains, transcriptional profiles revealed up-regulations of transcripts dps, hypR as well as dnaK and sigma factorV after exposure to TMPyP alone and to light-irradiated TMPyP. Specifically, the alternative sigma factorV reached up to 39 ± 113-fold (median ± IQR) (p = 0.0369) in strain A2. Up-regulation of the quorum sensing operon, fsr, and its downstream virulence-related gelatinase gelE were also observed in strains ATCC-29212, A1, A2 and UmID3. Finally, photo-oxidative stress induced vanA-type vancomycin-resistance gene in both carrier isolates, reaching up to 3.3 ± 17-fold in strain A2 (p = 0.015). These findings indicate that, while aPDT successfully inactivates vancomycin-resistant and naïve strains of E. faecalis, subpopulations of surviving cells respond by co-ordinately up-regulating a network of genes involved in stress survival and virulence. This includes the induction of vancomycin-resistance genes in carrier isolates. These data may provide the mechanistic basis to circumvent bacterial responses and improve future clinical protocols.


Asunto(s)
Enterococcus faecalis , Estrés Oxidativo , Fotoquimioterapia , Vancomicina , Antibacterianos/farmacología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Enterococcus faecalis/metabolismo , Enterococcus faecalis/patogenicidad , Pruebas de Sensibilidad Microbiana , Estrés Oxidativo/fisiología , Factor sigma/metabolismo , Vancomicina/farmacología , Virulencia/genética , Factores de Virulencia/genética , Factores de Virulencia/metabolismo
3.
J Endod ; 45(3): 295-301.e2, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30803536

RESUMEN

INTRODUCTION: Enterococcus faecalis is considered a predominant pathogen for persistent periapical infections and in addition is reportedly resistant to calcium hydroxide medication. The WalRK 2-component system of E. faecalis is essential for environmental adaptation, survival, and virulence. The goal of this study was to investigate the potential roles of walR in the regulation of biofilm aggregation, alkaline stress, and susceptibility to calcium hydroxide (CH) medication. METHODS: Antisense walR RNA (aswalR) overexpression strains were constructed. Exopolysaccharide (EPS) production and bacterial viability of E. faecalis biofilms were evaluated by confocal laser scanning microscopy. Quantitative real-time polymerase chain reaction was used to investigate the expressions of virulent factor genes. The proportion of viable bacteria and EPS production in dentin were assessed after CH medication. RESULTS: We showed that walR interference by aswalR RNA leads to a reduction in the dextran-dependent aggregation in E. faecalis biofilm. The overexpression of aswalR reduced the transcripts of the virulence genes and alkaline stress tolerance ability. Furthermore, the down-regulation of walR sensitized E. faecalis in infected canals to CH medication associated with inhibiting EPS synthesis. CONCLUSIONS: The data suggest a role for the walR regulator in the susceptibility to CH associated with dispelling the EPS matrix, which could be explored as a potential supplementary therapy for the management of root canal infection.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/genética , Proteínas Bacterianas/fisiología , Biopelículas , Hidróxido de Calcio/farmacología , Farmacorresistencia Bacteriana/genética , Enterococcus faecalis/genética , Enterococcus faecalis/fisiología , Genes Bacterianos/genética , Genes Bacterianos/fisiología , Adaptación Fisiológica/genética , Cavidad Pulpar/microbiología , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/patogenicidad , Humanos , Periodontitis Periapical/microbiología , Pulpitis/microbiología , Virulencia/genética
4.
Int. j. odontostomatol. (Print) ; 12(4): 355-361, dic. 2018. tab, graf
Artículo en Español | LILACS | ID: biblio-975757

RESUMEN

RESUMEN: El objetivo del estudio fue determinar el efecto antibacteriano in vitro de la oleorresina de Copaifera reticulata (C. reticulata) "copaiba" y del aceite esencial de Oreganum majoricum (O. majoricum) "orégano" frente a Streptococcus mutans (S. mutans) y Enterococcus faecalis (E. faecalis). Se desarrollaron pruebas de sensibilidad activando primero las cepas bacterias a enfrentar. La oleorresina de copaiba fue diluida con dimetilsulfósido (DMSO), obteniéndose al final concentraciones a probar de 100 %, 50 %, 25 %, y 12,5 %. En relación al aceite esencial de orégano este se probó solamente al 100 %. Para la prueba de difusión en agar con discos, se tomaron inóculos 100 µL de cada cepa bacteriana a una turbidez de 0,5 de Mc Farlam, para ser sembrados por diseminación en placas de tripticasa soya agar, para luego colocar los discos de forma equidistante cargados con las diferentes concentraciones de los productos naturales, se utilizaron como control positivo a la clorhexidina al 0,12 % y al DMSO como control negativo. Se incubaron las placas por el método de la vela en extinción a 37 °C, por un periodo de 24 horas, pasado el tiempo se realizó la lectura de los halos de inhibición. Los resultados obtenidos por la copaiba, determinaron un efecto antibacteriano en sus cuatro concentraciones, siendo los mayores halos de inhibición a la concentración del 100 %, copaiba genero mayores halos promedios para S, mutans de 30,00 ± 0,00 mm y para E. faecalis de 8,3 ± 0,50 mm. Para el caso del orégano se producen halos a la concentración del 100 % con un promedio de 25,3 ± 0,96 mm para S. mutans y para E. faecalis de 9,5 ± 1,29 mm. Se concluye del estudio que tanto copaiba como el orégano presentan un efecto antibacteriano para ambas bacterias, siendo su mayor efecto antibacteriano para ambos productos naturales sobre S. mutans.


ABSTRACT: The objective of the study was to determine the in vitro antibacterial effect of the oleoresin of Copaifera reticulata (C. reticulata) "copaiba" and of the essential oil of Oreganum majoricum (O. majoricum) "oregano" against Streptococcus mutans (S. mutans) and Enterococcus faecalis (E. faecalis). Sensitivity tests were developed by first activating the bacteria strains to be confronted. The oleoresin of copaiba was diluted with dimethylsulphoside (DMSO), obtaining final concentrations to be tested of 100 %, 50 %, 25 %, and 12.5 %. In relation to the essential oil of oregano, it was only 100 % tested. For the disk agar diffusion test, 100 mL of each bacterial strain was taken at a turbidity of 0.5 of Mc Farlam, to be planted by dissecting trypticase soy agar plates, and then placing the disks equidistantly loaded with the different concentrations of natural products; 0.12 % chlorhexidine was used as a positive control and DMSO as negative control. The plates were incubated by the candle method in extinction at 37 °C, for a period of 24 hours, after which time the inhibition halos were read. The results obtained by the copaiba, determined an antibacterial effect in its four concentrations, being the biggest halos of inhibition at the concentration of 100 %, copaiba genus higher average halos for S. mutans of 30.00 ± 0.00 mm and for E. faecalis of 8.3 ± 0.50 mm. In the case of oregano, haloes are produced at a concentration of 100 % with an average of 25.3 ± 0.96 mm for S. mutans and for E. faecalis 9.5 ± 1.29 mm. It is concluded from the study that both copaiba and oregano present an antibacterial effect for both bacteria, being its greater antibacterial effect for both natural products on S. mutans.


Asunto(s)
Humanos , Streptococcus mutans/fisiología , Extractos Vegetales/farmacología , Infecciones por Bacterias Grampositivas/microbiología , Infecciones por Bacterias Grampositivas/patología , Enterococcus faecalis/patogenicidad , Origanum/química , Perú , Streptococcus mutans/inmunología , Técnicas In Vitro , Aceites Volátiles/análisis , Antibacterianos
5.
Artículo en Inglés | MEDLINE | ID: mdl-30012755

RESUMEN

The Clinical and Laboratory Standards Institute (CLSI) daptomycin MIC susceptibility breakpoint for the treatment of enterococcal infections is ≤4 µg/ml. However, patients receiving daptomycin for the treatment of infections caused by enterococci with MICs of ≤4 µg/ml may experience treatment failures. We assessed the pharmacodynamics of daptomycin against enterococci in a neutropenic murine thigh infection model and determined the exposures necessary for bacteriostasis and a 1-log10-CFU reduction of Enterococcus faecalis and Enterococcus faecium We further characterized daptomycin efficacy at clinically achievable exposures. Six E. faecium and 6 E. faecalis isolates (daptomycin MICs, 0.5 to 32 µg/ml) were studied. Daptomycin was administered at various doses over 24 h to achieve area under the free drug concentration-time curve-to-MIC ratios (fAUC0-24/MIC) ranging from 1 to 148. Daptomycin regimens that simulate mean human exposures following doses of 6, 8, and 10 mg/kg of body weight/day were also studied. Efficacy was assessed by the differences in the number of log10 CFU per thigh at 24 h. The Hill equation was used to estimate the fAUC0-24/MIC required to achieve bacteriostasis and a 1-log10-CFU reduction. For E. faecium, a 1-log10-CFU reduction required an fAUC0-24/MIC of 12.9 (R2 = 0.71). For E. faecalis, a 1-log10-CFU reduction was not achieved, while the fAUC0-24/MIC required for stasis was 7.2 (R2 = 0.8). With a human-simulated regimen of 6 mg/kg/day, a 1-log10-CFU reduction was observed in 3/3 E. faecium isolates with MICs of <4 µg/ml and 0/3 E. faecium isolates with MICs of ≥4 µg/ml; however, a 1-log10-CFU reduction was not achieved for any of the 6 E. faecalis isolates. These results, alongside clinical data, prompt a reevaluation of the current breakpoint.


Asunto(s)
Antibacterianos/farmacocinética , Antibacterianos/uso terapéutico , Daptomicina/farmacocinética , Daptomicina/uso terapéutico , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecium/efectos de los fármacos , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Muslo/microbiología , Animales , Farmacorresistencia Bacteriana , Enterococcus faecalis/patogenicidad , Enterococcus faecium/patogenicidad , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Ratones , Pruebas de Sensibilidad Microbiana
6.
Photomed Laser Surg ; 35(4): 190-194, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28068207

RESUMEN

OBJECTIVE: This study examined the bactericidal effect of diode laser irradiation against intracanal Enterococcus faecalis. METHODS AND MATERIALS: m total of 128 extracted single-rooted and single-canal teeth were treated with ProTaper instruments (Dentsply Maillefer, Ballaigues, Switzerland). A total of 120 root canals were inoculated with E. faecalis for 21 days, and the samples were randomly divided into five groups: Group 1 (n = 24) samples were irrigated with only saline solution (positive controls); Group 2 (n = 24) was treated with only 5.25% sodium hypochlorite; Group 3 (n = 24) was irrigated with saline solutions activated by diode laser; Group 4 (n = 24) was treated with 5.25% sodium hypochlorite activated by diode laser; and Group 5 (n = 24) was irrigated with saline solution with methylene blue dye activated by the diode laser Fox (Sweden & Martina, Padova, Italy); additionally, eight teeth were not contaminated and their canals were irrigated with saline solution and used as a negative control. The Uro-Quick system was used to determine the microbial residual charge. The data were analyzed using Pearson's chi-square test (p < 0.001). RESULTS: A statistically significant reduction in bacterial count was observed in Group 2 and Group 4 (p < 0.001). There were no statistically significant differences among the other groups (p > 0.001). CONCLUSIONS: Evidence indicates that the diode laser was not more effective than sodium hypochlorite in reducing free bacteria.


Asunto(s)
Cavidad Pulpar/microbiología , Cavidad Pulpar/efectos de la radiación , Enterococcus faecalis/patogenicidad , Infecciones por Bacterias Grampositivas/radioterapia , Terapia por Luz de Baja Intensidad/métodos , Hipoclorito de Sodio/farmacología , Carga Bacteriana/efectos de la radiación , Enterococcus faecalis/efectos de los fármacos , Humanos , Técnicas In Vitro , Láseres de Semiconductores/uso terapéutico , Valores de Referencia , Tratamiento del Conducto Radicular/métodos , Sensibilidad y Especificidad , Extracción Dental
7.
Int J Food Sci Nutr ; 67(8): 1005-16, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27456160

RESUMEN

Drinking of cranberry fruit juice and application of commercial preparations containing the cranberry extracts are recommended in the prevention and treatment of urinary tract infections (UTIs), especially in women with recurrent UTIs. Many studies focus on the activity of cranberries against uropathogenic Escherichia coli (E. coli) strains. However, the knowledge of the cranberry effect on Gram-positive Enterococcus faecalis (E. faecalis) is limited. Therefore, the aim of our study was to establish the activity of commercial concentrated cranberry extract on the growth, virulence factors and biofilm formation of E. faecalis strains isolated from urine. Minimal inhibitory concentrations (MICs) of cranberry extract were determined by the broth microdilution method. Disc diffusion method was used to determine antimicrobial susceptibility. The impact of cranberry extract on bacterial survival, hydrophobicity, synthesis of lipase, lecithinase, DNase, hemolysin, gelatinase and biofilm mass was determined. Results show that cranberry extract inhibits the growth, enzymatic activities of bacteria and limits biofilm formation. The antibacterial activities of the studied cranberry extract confirm that it could be successfully used in prevention of UTIs caused by E. faecalis.


Asunto(s)
Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/patogenicidad , Infecciones por Bacterias Grampositivas/prevención & control , Infecciones Urinarias/prevención & control , Vaccinium macrocarpon/química , Biopelículas/efectos de los fármacos , Biopelículas/crecimiento & desarrollo , Enterococcus faecalis/fisiología , Jugos de Frutas y Vegetales/análisis , Genes Bacterianos/efectos de los fármacos , Infecciones por Bacterias Grampositivas/microbiología , Humanos , Técnicas In Vitro , Extractos Vegetales/farmacología , Infecciones Urinarias/microbiología , Factores de Virulencia/biosíntesis , Factores de Virulencia/genética
8.
J Endod ; 42(7): 1022-8, 2016 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27221594

RESUMEN

INTRODUCTION: The aim of this study was to investigate the prevalence of virulence factors and the antimicrobial resistance of Enterococcus faecalis isolates of teeth with failure of the endodontic treatment. METHODS: Twenty root canal samples were collected from teeth with apical periodontitis. E. faecalis was firstly identified based on phenotypic features and then by 16S ribosomal RNA gene sequencing. The antimicrobial susceptibility was determined by the minimum inhibitory concentration (MIC) of amoxicillin, amoxicillin + clavulanate, azithromycin, benzylpenicillin, ciprofloxacin, clindamycin, chloramphenicol, doxycycline, erythromycin, gentamicin, metronidazole, moxifloxacin, rifampicin, tetracycline, and vancomycin using the E test method. Virulence factors (ace, asa, asa373, cylA, efaA, esp, and gelE) were detected by polymerase chain reaction assay. RESULTS: Amoxicillin + clavulanate was effective against all strains. Intermediate and total resistance was found against the majority of the tested antimicrobials. The susceptibility of some microorganisms to some antimicrobial agents changed according to the evaluation time. MIC50 and MIC90 also varied according to the evaluation time. In relation to the virulence factors of the E faecalis isolates, ace was detected in 100% of the strains, asa (60%), asa373 (15%), efaA (95%), esp (70%), and gelE (75%), whereas cylA was not detected. CONCLUSIONS: It was concluded that E. faecalis isolates from persistent endodontic infections showed varied degrees of intermediate/total resistance to several antimicrobial agents, with amoxicillin + clavulanate being the most effective agent. Moreover, the strains showed different patterns for virulence gene detection.


Asunto(s)
Antibacterianos/farmacología , Cavidad Pulpar/microbiología , Farmacorresistencia Bacteriana/genética , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/genética , Factores de Virulencia/genética , Virulencia/genética , Adulto , Combinación Amoxicilina-Clavulanato de Potasio/farmacología , Enterococcus faecalis/aislamiento & purificación , Enterococcus faecalis/patogenicidad , Femenino , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Insuficiencia del Tratamiento
9.
Biomed Res Int ; 2016: 6705431, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-28097143

RESUMEN

In this study, methanol, ethyl acetate, water extracts, and precipitate were obtained from leaves of Malus domestica cultivars: Golden delicious, Jonagold, Elstar, Ligol, and Mutsu. Antiradical activity of these extracts was measured using the ABTS+∙ radical, and antimicrobial activity was measured with the disk-diffusion method. Phenolic compounds were measured with the colorimetric method and identified with high performance liquid chromatography (HPLC). The highest antiradical activity was observed for the Jonagold variety, and in particular strong activity was noted for ethyl acetate extracts. Antimicrobial activity was observed against strains of Staphylococcus aureus, Enterococcus faecalis, and the fungus Candida glabrata. Particularly susceptible to the extracts activity appeared to be Staphylococcus aureus, but the growth of Candida glabrata was inhibited in the presence of ethyl acetate extracts. With the HPLC method we identified a high amount of phloridzin (above 500 mg per g of ethyl acetate extracts), lower amounts of hyperoside, isoquercitrin, and quercitrin, and traces of p-hydroxybenzoic and chlorogenic acids. The contribution of phloridzin to antiradical activity of methanol and ethyl acetate extracts was very high (above 90%). In water extract the contribution of phloridzin was between 38.9 and 55.2%, chlorogenic acid 22.7 and 36.1%, and hyperoside 12.2 and 13.3%.


Asunto(s)
Antioxidantes/farmacología , Florizina/farmacología , Extractos Vegetales/farmacología , Polifenoles/farmacología , Antioxidantes/química , Candida glabrata/efectos de los fármacos , Candida glabrata/patogenicidad , Cromatografía Líquida de Alta Presión , Colorimetría , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/patogenicidad , Depuradores de Radicales Libres/química , Humanos , Malus/química , Florizina/química , Florizina/aislamiento & purificación , Extractos Vegetales/química , Hojas de la Planta/química , Polifenoles/química , Staphylococcus aureus/efectos de los fármacos , Staphylococcus aureus/patogenicidad
10.
PLoS Pathog ; 10(6): e1004210, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24967632

RESUMEN

The ability of innate immune cells to sense and respond to impending danger varies by anatomical location. The liver is considered tolerogenic but is still capable of mounting a successful immune response to clear various infections. To understand whether hepatic immune cells tune their response to different infectious challenges, we probed mononuclear cells purified from human healthy and diseased livers with distinct pathogen-associated molecules. We discovered that only the TLR8 agonist ssRNA40 selectively activated liver-resident innate immune cells to produce substantial quantities of IFN-γ. We identified CD161(Bright) mucosal-associated invariant T (MAIT) and CD56(Bright) NK cells as the responding liver-resident innate immune cells. Their activation was not directly induced by the TLR8 agonist but was dependent on IL-12 and IL-18 production by ssRNA40-activated intrahepatic monocytes. Importantly, the ssRNA40-induced cytokine-dependent activation of MAIT cells mirrored responses induced by bacteria, i.e., generating a selective production of high levels of IFN-γ, without the concomitant production of TNF-α or IL-17A. The intrahepatic IFN-γ production could be detected not only in healthy livers, but also in HBV- or HCV-infected livers. In conclusion, the human liver harbors a network of immune cells able to modulate their immunological responses to different pathogen-associated molecules. Their ability to generate a strong production of IFN-γ upon stimulation with TLR8 agonist opens new therapeutic opportunities for the treatment of diverse liver pathologies.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Inmunidad Innata/efectos de los fármacos , Leucocitos Mononucleares/efectos de los fármacos , Hígado/efectos de los fármacos , Oligorribonucleótidos/farmacología , Receptor Toll-Like 8/agonistas , Regulación hacia Arriba/efectos de los fármacos , Células Cultivadas , Técnicas de Cocultivo , Enterococcus faecalis/inmunología , Enterococcus faecalis/metabolismo , Enterococcus faecalis/patogenicidad , Escherichia coli/inmunología , Escherichia coli/metabolismo , Escherichia coli/patogenicidad , Hepacivirus/inmunología , Hepacivirus/patogenicidad , Hepatitis B/inmunología , Hepatitis B/metabolismo , Hepatitis B/patología , Hepatitis B/virología , Virus de la Hepatitis B/inmunología , Virus de la Hepatitis B/patogenicidad , Hepatitis C/inmunología , Hepatitis C/metabolismo , Hepatitis C/patología , Hepatitis C/virología , Humanos , Ensayos de Liberación de Interferón gamma , Células Asesinas Naturales/efectos de los fármacos , Células Asesinas Naturales/inmunología , Células Asesinas Naturales/metabolismo , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Leucocitos Mononucleares/patología , Hígado/inmunología , Hígado/microbiología , Hígado/patología , Monocitos/efectos de los fármacos , Monocitos/inmunología , Monocitos/metabolismo , Pseudomonas aeruginosa/inmunología , Pseudomonas aeruginosa/metabolismo , Pseudomonas aeruginosa/patogenicidad , Riboflavina/biosíntesis , Subgrupos de Linfocitos T/efectos de los fármacos , Subgrupos de Linfocitos T/inmunología , Subgrupos de Linfocitos T/metabolismo , Receptor Toll-Like 8/metabolismo
11.
Rev. Inst. Nac. Hig ; 43(2): 9-11, dic. 2012. tab, ilus
Artículo en Español | LILACS, LIVECS | ID: lil-702804

RESUMEN

El objetivo de esta investigación fue determinar la actividad antibacteriana del extracto etanolico de las hojas y el extracto hexanoico obtenido de los frutos del Schinus molle L. (Anacardiaceae), cultivado en Italia, con un rendimiento de 32,42 % y 5,63 %, respectivamente. Independientemente del tipo de extracto y de la parte de la planta utilizada, el Schinus molle L., mostró una buena actividad antibacteriana contra bacterias Gram positivas (S. aureus ATCC 29213 y E. faecalis ATCC 29212) con una CMI 16 µg/mL. El rango de CBM de estas bacterias estuvo entre 32 y 64 mg/mL, respectivamente.


The aim of this research was to determine antibacterial activity of etanolic extract of the leaves and hexanoic extract obtained from fruits of Schinus molle L. (Anacardiaceae), grown in Italia. with a yield of 32,42 % and 5,63 %, respectively. Whatever type of extract and the plant part used, Schinus molle L., showed good antibacterial activity against Gram positive bacteria (S. aureus ATCC 29213 and E. faecalis ATCC 29212) with MIC 16 mg/mL. Range of MBC of these bacteria were between 32 and 64 mg/mL respectively.


Asunto(s)
Masculino , Infecciones Bacterianas/virología , Schinus molle/análisis , Enterococcus faecalis/patogenicidad , Antibacterianos/uso terapéutico , Plantas Medicinales , Staphylococcus aureus/metabolismo , Salud Pública
12.
Eur J Clin Microbiol Infect Dis ; 31(10): 2545-7, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22395262

RESUMEN

Aminoglycosides are recommended for the treatment of Enterococcus faecalis infections, especially in severe and bacteremic infection. However, the optimal aminoglycoside or the optimal dosage remains uncertain. This study aimed to compare the activity of four aminoglycosides against E. faecalis (gentamicin, netilmicin, tobramycin, and amikacin) and two dosages of gentamicin. One clinical strain of E. faecalis was used to induce aortic endocarditis in the study rabbits. Each aminoglycoside was infused daily over 3 days with a computer-regulated flow simulating human pharmacokinetics of 15 mg/kg/day for amikacin, 6 mg/kg/day for netilmicin, and 3 mg/kg/day for gentamicin and tobramycin. Additionally, two dosages of gentamicin (simulating 3 or 6 mg/kg/day) were compared over 1 or 3 days of treatment. The in vivo efficacy was assessed according to the bacterial count in vegetations, in comparison with a control group. Of the four aminoglycosides tested, only gentamicin and netilmicin showed significant antibacterial efficacy after 3 days of treatment. After only 1 day of treatment, the high dosage of gentamicin (6 mg/kg/day) was more effective than the standard dosage (3 mg/kg/day). Among the tested aminoglycosides, gentamicin showed the best efficacy, with the best results after 24 h of treatment for the highest dosage.


Asunto(s)
Endocarditis Bacteriana/tratamiento farmacológico , Gentamicinas/administración & dosificación , Gentamicinas/farmacología , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Amicacina/administración & dosificación , Amicacina/farmacología , Animales , Antibacterianos/administración & dosificación , Antibacterianos/uso terapéutico , Carga Bacteriana , Modelos Animales de Enfermedad , Esquema de Medicación , Evaluación Preclínica de Medicamentos , Endocarditis Bacteriana/microbiología , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/patogenicidad , Femenino , Infecciones por Bacterias Grampositivas/microbiología , Netilmicina/administración & dosificación , Netilmicina/farmacología , Conejos , Factores de Tiempo , Tobramicina/administración & dosificación , Tobramicina/farmacología
13.
Urol Int ; 88(2): 198-208, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22237308

RESUMEN

BACKGROUND: Urinary tract infections (UTIs) can be hard to treat and treatment plans need to include accurate categorization such as uncomplicated or complicated UTI, or catheterized or uncatheterized UTI. We investigated the antibiotic susceptibilities of representative uropathogens in UTI categories. METHODS: We isolated uropathogens and analyzed their antimicrobial susceptibilities according to UTI categorization such as: (1) urology outpatients, urology inpatients, or other department inpatients; (2) uncomplicated or complicated UTIs; (3) upper or lower UTIs, and (4) non-catheterized or catheterized UTIs. RESULTS: Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa were representative uropathogens. Susceptibilities to levofloxacin (LVFX) in E. coli in urology outpatients (p = 0.0179), those to ceftadizime in E. coli in other department inpatients (p = 0.0327), and those to LVFX in E. faecalis in complicated UTI (p = 0.0137) significantly decreased in these 3 years compared with the previous 3 years. Susceptibilities of upper UTI to LVFX in E. coli were significantly lower in the recent 4 years compared to lower UTI (p = 0.0452) and those of catheterized UTI to LVFX in E. faecalis were significantly lower than in non-catheterized UTI (p = 0.0153). CONCLUSIONS: Data demonstrated different tendencies of uropathogens' antibiotic susceptibilities according to UTI categorizations and they could be useful for planning UTI treatments.


Asunto(s)
Antiinfecciosos/uso terapéutico , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Infecciones Relacionadas con Catéteres/microbiología , Pacientes Internos/clasificación , Pacientes Ambulatorios/clasificación , Cateterismo Urinario/clasificación , Infecciones Urinarias/tratamiento farmacológico , Infecciones Urinarias/microbiología , Infecciones Relacionadas con Catéteres/clasificación , Infecciones Relacionadas con Catéteres/diagnóstico , Ceftazidima/uso terapéutico , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/patogenicidad , Escherichia coli/efectos de los fármacos , Escherichia coli/patogenicidad , Humanos , Japón , Levofloxacino , Pruebas de Sensibilidad Microbiana , Ofloxacino/uso terapéutico , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/patogenicidad , Factores de Tiempo , Cateterismo Urinario/efectos adversos , Infecciones Urinarias/clasificación , Infecciones Urinarias/diagnóstico , Servicio de Urología en Hospital/clasificación
14.
Res Microbiol ; 159(9-10): 595-601, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18845249

RESUMEN

In contrast to breast milk, little is known about the bacterial composition of human colostrum. The objective of this work was to analyze the bacterial diversity of colostrum obtained from healthy women and to characterize the dominant bacterial species for the presence of possible virulence factors. Samples of colostrum obtained from 36 healthy women were inoculated into different culture media. Several isolates from each medium were selected and identified. Staphylococcal and enterococcal isolates were submitted to genetic profiling. One representative of each profile was included in a genetic and phenotypic characterization scheme, including detection of potential virulence traits/genes and sensitivity to antibiotics. Staphylococcus epidermidis and Enterococcus faecalis were the dominant species, followed by Streptococcus mitis, Propionibacterium acnes and Staphylococcus lugdunensis. Among the 48 S. epidermidis isolates selected on the basis of their genetic profiles, the biofilm-related icaD gene and the mecA gene were detected in only 11 and six isolates, respectively. In parallel, 10 enterococcal isolates were also characterized and none of them contained the cylA, vanA, vanB, vanD, vanE and vanG genes. All of them were sensitive to vancomycin. There were no indications that the colostrum samples contained harmful bacteria.


Asunto(s)
Proteínas Bacterianas/genética , Calostro/microbiología , Bacterias Grampositivas , Factores de Virulencia/genética , Medios de Cultivo , Enterococcus faecalis/genética , Enterococcus faecalis/aislamiento & purificación , Enterococcus faecalis/patogenicidad , Femenino , Bacterias Grampositivas/clasificación , Bacterias Grampositivas/genética , Bacterias Grampositivas/aislamiento & purificación , Bacterias Grampositivas/patogenicidad , Humanos , Propionibacterium acnes/genética , Propionibacterium acnes/aislamiento & purificación , Propionibacterium acnes/patogenicidad , Staphylococcus/genética , Staphylococcus/aislamiento & purificación , Staphylococcus/patogenicidad , Streptococcus mitis/genética , Streptococcus mitis/aislamiento & purificación , Streptococcus mitis/patogenicidad
16.
J Med Microbiol ; 52(Pt 2): 113-119, 2003 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-12543916

RESUMEN

There is increasing recognition of the emerging role of manganese regulation and acquisition in some pathogenic bacteria. Expression of the Enterococcus faecalis endocarditis-associated virulence factor EfaA is induced by growth in serum. It is demonstrated here that expression of the efaCBA operon encoding a putative ABC-type transporter is regulated by Mn(2+). Transcription of efaCBA and EfaA production were repressed in Mn(2+)-supplemented medium. A Mn(2+)-responsive transcriptional regulator, EfaR, sharing 27 % identity with the Corynebacterium diphtheriae diphtheria toxin repressor (DtxR), was identified. In the presence of Mn(2+), EfaR protein bound in vitro to the efaC promoter region. Analysis of the E. faecalis V583 genome revealed ten additional putative EfaR-binding sites, suggesting that manganese availability could have a broader regulatory role in infection. The results identify a new Mn(2+)-sensing regulator in enterococci that regulates the expression of a virulence factor implicated in enterococcal endocarditis.


Asunto(s)
Antígenos Bacterianos , Proteínas Bacterianas/biosíntesis , Endocarditis Bacteriana/microbiología , Enterococcus faecalis/patogenicidad , Infecciones por Bacterias Grampositivas/microbiología , Manganeso/fisiología , Factores de Virulencia/biosíntesis , Secuencia de Aminoácidos , Proteínas Bacterianas/química , Proteínas Bacterianas/genética , Secuencia de Bases , Western Blotting , Enterococcus faecalis/genética , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Regulación Bacteriana de la Expresión Génica/fisiología , Manganeso/farmacología , Datos de Secuencia Molecular , Operón/genética , Regiones Promotoras Genéticas , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Virulencia , Factores de Virulencia/genética , Factores de Virulencia/metabolismo
17.
Vet Q ; 21(3): 78-82, 1999 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10427631

RESUMEN

The present paper presents an overview of current knowledge of amyloid arthropathy in chickens, and covers the pathogenesis of amyloidosis in general and in birds, field cases reported, and the studies performed to assess the amyloidogenicity of various agents compared to that of Enterococcus faecalis. An animal model of amyloid arthropathy is presented, as are studies on the pathogenesis of arthropathic and amyloidogenic E. faecalis infections in brown layers. The review concludes with a description of the pathology of amyloid arthropathy, the biochemical characterization of the chicken joint amyloid protein as being of the AA type, investigation of the serum amyloid A (SAA) gene involved, and local SAA mRNA expression in joint and liver.


Asunto(s)
Amiloidosis/veterinaria , Artritis/veterinaria , Enfermedades de las Aves de Corral/etiología , Tesis Académicas como Asunto , Amiloidosis/etiología , Amiloidosis/metabolismo , Amiloidosis/microbiología , Animales , Artritis/etiología , Artritis/metabolismo , Artritis/microbiología , Pollos , Modelos Animales de Enfermedad , Enterococcus faecalis/patogenicidad , Hígado/metabolismo , Enfermedades de las Aves de Corral/metabolismo , Enfermedades de las Aves de Corral/microbiología , ARN Mensajero/biosíntesis , Proteína Amiloide A Sérica/análisis , Proteína Amiloide A Sérica/genética , Proteína Amiloide A Sérica/metabolismo , Membrana Sinovial/metabolismo
18.
J Infect Dis ; 169(4): 821-30, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8133097

RESUMEN

Two nonfatal models of peritonitis differing by the duration and the severity of the disease were studied in rats by implantation of Escherichia coli and Bacteroides fragilis with or without increasing concentrations of Enterococcus faecalis. Results were evaluated at 3 or 6 days after inoculation. The highest enterococcal concentrations (10(9) cfu/mL) enhanced the severity of the infection, evident by increased emaciation, increased peritoneal counts of E. coli and B. fragilis, and increased frequency of E. coli and B. fragilis bacteremia compared with enterococcus-free animals. Six therapeutic regimens (low-dose amoxicillin + low-dose gentamicin, high-dose amoxicillin + high-dose gentamicin, pefloxacin, ornidazole, pefloxacin + ornidazole, imipenem + gentamicin) were tested. All treatments failed to eradicate E. faecalis except the combination pefloxacin + ornidazole, which achieved a significant reduction of local bacterial counts and suppressed bacteremia. Enterococcus played an important role in the mechanisms of bacterial synergy in experimental peritonitis. However, eradication of enterococcus did not seem possible by conventional antienterococcal therapy.


Asunto(s)
Antibacterianos/uso terapéutico , Enterococcus faecalis/patogenicidad , Infecciones por Bacterias Grampositivas/microbiología , Peritonitis/microbiología , Absceso/tratamiento farmacológico , Absceso/microbiología , Amoxicilina/farmacología , Amoxicilina/uso terapéutico , Animales , Antibacterianos/farmacología , Bacteriemia/tratamiento farmacológico , Bacteriemia/microbiología , Infecciones por Bacteroides/complicaciones , Bacteroides fragilis/patogenicidad , Peso Corporal , Modelos Animales de Enfermedad , Sinergismo Farmacológico , Enterococcus faecalis/efectos de los fármacos , Escherichia coli/patogenicidad , Infecciones por Escherichia coli/complicaciones , Gentamicinas/farmacología , Gentamicinas/uso terapéutico , Infecciones por Bacterias Grampositivas/complicaciones , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Imipenem/farmacología , Imipenem/uso terapéutico , Masculino , Pruebas de Sensibilidad Microbiana , Ornidazol/farmacología , Ornidazol/uso terapéutico , Pefloxacina/farmacología , Pefloxacina/uso terapéutico , Peritoneo/microbiología , Peritonitis/tratamiento farmacológico , Ratas , Ratas Sprague-Dawley , Organismos Libres de Patógenos Específicos
19.
Urology ; 27(4): 343-8, 1986 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-3083556

RESUMEN

The first step in developing a bladder infection is attachment of bacteria to the bladder epithelium. Removing the bladder mucin increases bacterial adherence up to a thousand-fold, and this increase can be prevented by pretreating the mucin-deficient bladder with heparin. To develop a rapid, in vitro antiadherence screening assay, we studied the adherence of Escherichia coli to various chromatography resins and the ability of heparin and other agents to antagonize this attachment. The results can be summarized as follows: Although E. coli attached to all resins, only the adherence to the anion exchange resin was inhibited by heparin (up to 95%). Agents which did not effect E. coli adherence to the resin did not affect attachment to the bladder. Agents which inhibited E. coli adherence to the bladder also inhibited E. coli adherence to the resin. Similar to the effect of heparin on E. coli attachment, the adherence of Klebsiella ozaene, Proteus mirabilis, and Streptococcus fecalis to both bladder epithelium and anion exchange resin were also antagonized. These studies indicate that the adherence of E. coli (as well as other bacterial species) to anion exchange resin responds to heparin and other chemical agents in a similar manner as does adherence to the mucin-deficient rabbit urinary bladder. Because of the ease and rapid nature of this in vitro assay, it serves as a useful screen for potential bacterial antiadherence agents and could be used to help elucidate mechanisms of bacterial attachment.


Asunto(s)
Resinas de Intercambio Aniónico/farmacología , Escherichia coli/efectos de los fármacos , Resinas de Intercambio Iónico/farmacología , Adhesividad , Animales , Bioensayo/métodos , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/patogenicidad , Escherichia coli/patogenicidad , Heparina/farmacología , Técnicas In Vitro , Klebsiella/efectos de los fármacos , Klebsiella/patogenicidad , Mucinas/deficiencia , Proteus mirabilis/efectos de los fármacos , Proteus mirabilis/patogenicidad , Conejos , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA